<DOC>
	<DOCNO>NCT00575029</DOCNO>
	<brief_summary>Megestrol Acetate ( MA ) progesterone-like hormone utilized birth control agent , chemotherapeutic drug , recently , induce appetite weight gain patient malnourish result radiation therapy , chemotherapy , cystic fibrosis , AIDS , dementia . The mechanism MA-stimulated appetite weight gain unknown . Although approved combat weight loss associate AIDS cancer , MA frequently prescribe long period time prevent reverse weight loss nursing home resident elderly patient serious illness community . Little data available support practice . Among many property , MA act partial glucocorticoid agonist , long term short term use MA may result adrenal suppression . The rapidity onset MA-induced adrenal suppression time course resumption normal adrenal function discontinuation MA completely unknown . As consequence , unclear whether MA give safely short period time whether glucocorticoid administration necessary abruptly stop MA treatment . The increase use MA frail elderly , even partial adrenal insufficiency may pose substantial risk adrenal crisis illness , require clear understanding issue . To address concern , evaluate adrenal function , , MA administration healthy volunteer age 60 85 year .</brief_summary>
	<brief_title>Adrenal Suppression Adrenal Recovery Induced Megestrol Acetate</brief_title>
	<detailed_description />
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Elderly male female Age 6580 year With stable ( history urgent/ emergent care visit health care provider/s precede 2 month ) , medical condition Subjects exclude history ( H/O ) : Dementia Adrenal disease Thromboembolism Diabetes mellitus Liver disease Electrolyte abnormalities ; Vaginal bleeding Hypertriglyceridemia CAD CHF Unstable depression Schizophrenia ; Morbidly obese subject .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>megestrol acetate</keyword>
	<keyword>adrenal insufficiency</keyword>
	<keyword>adrenal suppression</keyword>
</DOC>